VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,801,892 | -35.5% | 2,007,946 | 0.0% | 0.61% | -32.8% |
| Q2 2023 | $47,769,035 | -6.5% | 2,007,946 | 0.0% | 0.90% | -22.0% |
| Q1 2023 | $51,082,146 | +98.7% | 2,007,946 | +128.2% | 1.16% | +121.9% |
| Q4 2022 | $25,704,800 | +42.4% | 880,000 | 0.0% | 0.52% | +35.3% |
| Q3 2022 | $18,049,000 | +106070.6% | 880,000 | +85006.4% | 0.38% | – |
| Q3 2021 | $17,000 | -99.7% | 1,034 | -99.7% | 0.00% | -100.0% |
| Q2 2021 | $5,712,000 | +9.4% | 312,328 | 0.0% | 0.09% | +16.5% |
| Q1 2021 | $5,219,000 | – | 312,328 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |